WNTinib (APS-8-100-2) is a multi-kinase inhibitor that selectively antagonizes beta-catenin (CTNNB1) mutated hepatocellular carcinoma (HCC). WNTinib downregulates oncogenicWntsignaling by inhibiting KIT/MAPK and downstream EZH2 activation[1].
Molecular Weight:
498.38
Purity:
99.95
CAS Number:
[2770091-44-4]
Formula:
C22H16F6N4O3
Target:
Apoptosis,Wnt
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted